BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8916480)

  • 1. Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial.
    Lees RS; Pitt B; Chan RC; Holmvang G; Dinsmore RE; Campbell LW; Haber HE; Klibaner MI; Cashin-Hemphill L
    Am J Cardiol; 1996 Nov; 78(9):1011-6. PubMed ID: 8916480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
    Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
    Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.
    Pitt B; O'Neill B; Feldman R; Ferrari R; Schwartz L; Mudra H; Bass T; Pepine C; Texter M; Haber H; Uprichard A; Cashin-Hemphill L; Lees RS;
    Am J Cardiol; 2001 May; 87(9):1058-63. PubMed ID: 11348602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
    Okimoto T; Imazu M; Hayashi Y; Gomyo Y; Sekiguchi Y; Yanagihara K; Shimohara Y; Sumii K; Yamamoto H; Tadehara F; Toyofuku M; Kohno N
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):323-9. PubMed ID: 11800416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
    Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.
    Texter M; Lees RS; Pitt B; Dinsmore RE; Uprichard AC
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):273-82. PubMed ID: 8357782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.
    Meurice T; Bauters C; Hermant X; Codron V; VanBelle E; Mc Fadden EP; Lablanche J; Bertrand ME; Amouyel P
    Lancet; 2001 Apr; 357(9265):1321-4. PubMed ID: 11343737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
    Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
    Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
    Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH
    Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound.
    Kondo J; Sone T; Tsuboi H; Mukawa H; Kosokabe T; Tsuzuki M; Tomida T; Suzuki T; Kamiya H; Hayashi K; Matsui H; Okumura K
    Am J Cardiol; 2001 Feb; 87(4):443-5, A6. PubMed ID: 11179530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril for coronary artery disease.
    Seth S; Mohan A
    Natl Med J India; 1997; 10(2):73-4. PubMed ID: 9153985
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study).
    Dzavik V; Beanlands DS; Davies RF; Leddy D; Marquis JF; Teo KK; Ruddy TD; Burton JR; Humen DP
    Am J Cardiol; 1994 May; 73(12):856-61. PubMed ID: 8184807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.
    Otsuka M; Yamamoto H; Okimoto T; Dohi Y; Mito S; Gomyo Y; Fujii T; Matsuura W; Hirai Y; Kohno N
    Am Heart J; 2004 Apr; 147(4):662-8. PubMed ID: 15077082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
    Hügel S; Horn M; Remkes H; Dienesch C; Neubauer S
    J Cardiovasc Magn Reson; 2001; 3(3):215-25. PubMed ID: 11816618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of quinapril initiated during progressive remodeling in asymptomatic patients with healed myocardial infarction.
    Gaudron P; Kugler L; Hu K; Fraccarollo D; Bauer W; Eilles C; Ertl G
    Am J Cardiol; 2000 Jul; 86(2):139-44. PubMed ID: 10913472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinapril and blood lipids.
    Koskinen P; Manninen V; Eisalo A
    Br J Clin Pharmacol; 1988 Oct; 26(4):478-80. PubMed ID: 3190999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.